Chronic heart failure in adults: diagnosis and managementStatus:In developmentProgramme:NICE guidelineExpected publication date: 3 September 2025
Venoarterial extracorporeal membrane oxygenation (VA ECMO) for acute heart failure in adultsStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 15 October 2025
Venoarterial Extracorporeal membrane oxygenation (VA ECMO) for postcardiotomy cardiogenic shock in adultsStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 15 October 2025
Digital platforms to support cardiac rehabilitation: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 18 November 2025
Pulmonary artery pressure technologies for remote monitoring of chronic heart failureStatus:In developmentProgramme:Diagnostics guidanceExpected publication date: 20 January 2026
Insertion of a catheter-based intravascular microaxial flow pump for cardiogenic shockStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 25 March 2026
Artificial Intelligence assisted Echocardiography to support diagnosis of heart failure: Early Value AssessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 19 May 2026
Evolocumab for preventing major cardiovascular events in people aged 50 to 79 at high risk who have not had a myocardial infarction or stroke TS ID 11920Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Finerenone for treating heart failure with preserved or mildly reduced ejection fraction ID6514Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC